Laxatives: Drug Classes, Mechanisms, and Nursing Considerations

Laxatives are commonly tested in nursing pharmacology because each class works differently, has its own onset time, and carries specific safety concerns. This guide reviews the major classes, their mechanisms, key side effects, and the patient situations where each is preferred or avoided.

Overview of Laxative Drug Classes

• Bulk-Forming — Psyllium (Metamucil), Polycarbophil. Absorb water to increase stool bulk and stimulate peristalsis. Must be taken with a full glass of water; onset 12–72 hours; can treat both constipation and diarrhea.
• Stool Softeners (Surfactants) — Docusate (Colace). Facilitate water and fat penetration into stool. Preferred post-MI or post-surgery to prevent straining; onset 12–72 hours.
• Osmotic Agents — Polyethylene glycol (Miralax), Lactulose, Magnesium citrate. Draw water into the colon to soften stool. Lactulose also treats hepatic encephalopathy by lowering ammonia; magnesium-based agents are contraindicated in renal impairment.
• Stimulants — Bisacodyl (Dulcolax), Senna. Increase peristalsis by irritating intestinal mucosa. Cause cramping; high abuse potential; onset 6–12 hours.
• Lubricants — Mineral oil. Coats stool and intestinal wall for smooth passage. Aspiration risk; interferes with vitamin absorption; not for bedridden patients.
• Chloride Channel Activators — Lubiprostone (Amitiza). Increases intestinal fluid secretion. Used for IBS with constipation in women; contraindicated in GI obstruction.

Bulk-Forming Laxatives

• Psyllium absorbs water to increase stool bulk and stimulate peristalsis.
• Safest class for long-term constipation management.
• Must be taken with at least 8 oz of water to prevent choking or obstruction.
• Onset: 12–72 hours.
• Can cause bloating and mild cramping initially.
• Administer 2 hours apart from other medications to prevent absorption interference.

Stool Softeners (Surfactants)

• Docusate allows water and fats to penetrate stool, making it softer.
• Preferred for patients who should avoid straining: post-MI, post-surgery, post-partum.
• Best for prevention, not treatment of acute constipation.
• Onset: 12–72 hours.
• Often ordered PRN for opioid-induced constipation.

Osmotic Laxatives

• Polyethylene glycol (PEG 3350) draws water into the colon to soften stool.
• Lactulose treats constipation and hepatic encephalopathy by lowering ammonia.
• Magnesium citrate and milk of magnesia are contraindicated in renal impairment.
• Side effects: bloating, gas, cramping, diarrhea, and possible dehydration/electrolyte imbalance.
• Bowel prep solutions like GoLYTELY contain PEG plus electrolytes to prevent dehydration.

Stimulant Laxatives

• Bisacodyl and senna irritate intestinal mucosa to increase peristalsis.
• Onset: 6–12 hours (oral), 15–60 minutes (suppository).
• Common side effects: abdominal cramping, diarrhea.
• Long-term use can cause dependence (cathartic colon).
• Chronic use may lead to electrolyte imbalance, especially hypokalemia, causing cardiac complications.

Lubricant Laxatives

• Mineral oil coats stool and intestinal wall for smooth passage.
• Aspiration risk is significant, especially in bedridden or elderly patients.
• Interferes with fat-soluble vitamin (A, D, E, K) absorption with long-term use.
• Should not be given with meals or to patients with swallowing difficulties.
• Onset: 6–8 hours; available as oral liquid or enema.

Chloride Channel Activators

• Lubiprostone increases intestinal fluid secretion.
• Indicated for IBS-C in women.
• Contraindicated in mechanical GI obstruction.
• Nausea can occur; taking with food can reduce it.

Laxative Safety and Dependence

• Chronic overuse, especially of stimulants, can cause bowel dependence.
• Electrolyte abnormalities including hypokalemia and hyponatremia are serious risks of chronic use.
• Laxative misuse is sometimes seen in eating disorders (bulimia, anorexia).
• Non-pharmacologic measures (hydration, dietary fiber, exercise) should always be tried first.
• Patients should know that daily bowel movements are not required; normal patterns vary.

Pregnancy and Special Populations

• Bulk-forming laxatives are safest in pregnancy.
• Stimulant laxatives (e.g., castor oil) should be avoided in pregnancy.
• Stool softeners prevent straining in post-MI or post-surgery patients.
• Magnesium-based osmotics are contraindicated in renal impairment.
• Stimulants should be used cautiously in children.

Common Exam Traps

• Docusate prevents constipation but does not treat acute constipation.
• Magnesium-based laxatives are contraindicated in renal failure.
• Bulk-forming laxatives require adequate water intake.
• Long-term stimulant use can cause dependence and electrolyte loss.
• Lactulose treats both constipation and hepatic encephalopathy.
• Stool softeners prevent straining, reducing vagal stimulation and arrhythmia risk.
• Bulk-formers and stool softeners take 1–3 days — do not expect immediate effect.

Key takeaways

• Bulk-forming laxatives (psyllium) are the safest for long-term use but require a full glass of water and take 1–3 days to work.
• Docusate is for prevention of straining (post-MI, post-op, opioid use), not for acute constipation relief.
• Lactulose has a dual role: constipation and hepatic encephalopathy (lowers ammonia).
• Magnesium-based osmotics are contraindicated in renal impairment.
• Stimulant laxatives work fastest (6–12 hr oral; 15–60 min suppository) but cause cramping, dependence, and hypokalemia with chronic use.
• Mineral oil carries aspiration risk and blocks absorption of fat-soluble vitamins (A, D, E, K).